We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Merck KGAA | TG:MRK | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.65 | 1.61% | 167.05 | 166.25 | 167.80 | 167.00 | 164.00 | 165.35 | 4,547 | 22:50:02 |
From Jun 2023 to Jun 2024
By Colin Kellaher
Shares of Exscientia rose sharply in premarket trading Wednesday after the precision-medicine company formed an artificial-intelligence collaboration potentially worth hundreds of millions of dollars with German science and technology company Merck KGaA.
As part of the multi-year agreement, Exscientia said it will receive a $20 million upfront payment from Merck and will be eligible for up to $674 million in milestone payments, along with royalties on product sales.
Exscientia said the companies will use its AI-driven precision drug design and discovery capabilities to discover novel small-molecule drug candidates across oncology, neuroinflammation and immunology.
Exscientia shares, which closed Tuesday at $5.06, were recently up 21% to $6.14 in premarket trading.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
September 20, 2023 06:32 ET (10:32 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Merck KGAA Chart |
1 Month Merck KGAA Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
